Indivior Inc. Indicted for Fraudulently Marketing Prescription Opioid

VA 2026 Independent Pharmacies

OIG Controlled Substance

Penalty

Outcome

OIG enforcement action against Indivior Inc. Indicted for Fraudulently Marketing Prescription Opioid for controlled substance.

Details

Indivior Inc. Indicted for Fraudulently Marketing Prescription Opioid — OIG Enforcement (2026)

OIG took enforcement action against Indivior Inc. Indicted for Fraudulently Marketing Prescription Opioid in VA in 2026 involving controlled substance violations in the Independent Pharmacies sector.

Violation types: Controlled Substance
Entity type: Pharmacy
Penalty type: Settlement
Location: VA

Source: Indivior Inc. Indicted for Fraudulently Marketing Prescription Opioid

How Crucible Prevents This

Crucible's controlled substance tracking enforces DEA-compliant inventory reconciliation, flags prescribing pattern anomalies, and requires segregation of duties for dispensing and record-keeping.

Source: Indivior Inc. Indicted for Fraudulently Marketing Prescription Opioid

Don't let this happen to your organization. See how Crucible works.

See How Crucible Works